MitoTEMPO hydrate

167 Cited Publications
Customer Review

Based on 167 publication(s) in Google Scholar

MitoTEMPO hydrate is a mitochondria-targeted antioxidant. MitoTEMPO hydrate induces mitophagy by activating the PINK1/Parkin pathway, inhibits NLRP3 inflammasome activation, restores mitochondrial membrane potential, and improves renal function and podocyte injury. MitoTEMPO hydrate regulates Ca2+ homeostasis, inhibits Bnip3 overexpression, shortens action potential duration, and exerts antiarrhythmic effects. MitoTEMPO hydrate reverses premature senescence, reduces trabecular bone loss, and decreases cell apoptosis. MitoTEMPO hydrate can be used in studies of chronic kidney disease, age-related cardiac dysfunction, postmenopausal osteoporosis, and ischemic stroke.

For research use only. We do not sell to patients.

  • Purity: 98.03%
  • CAS No.: 1569257-94-8
  • Formula: C29H37ClN2O3P
  • Molecular Weight:528.04
  • Storage:

    -20°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need

Publications Citing Use of MedChemExpress (MCE) MitoTEMPO hydrate

More
Customer Validation & Images
WBIF
  • IF
  • WB
  • WB

All NOD-like Receptor (NLR) Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00